Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Switzerland Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20041
20051
20062
20082
20101
20172
20182
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi5
Boehringer Ingelheim2
Daiichi Sankyo2
Bayer1
Bristol-Myers Squibb1
CSL Behring1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Gruppo di Ricerca GISSI1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation17
Stroke4
Arrhythmias, Cardiac2
Atrial Flutter2
Cardiovascular Diseases2
Embolism2
Heart Diseases2
Acute Coronary Syndrome1
Atherosclerosis1
Coronary Artery Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.